Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis

BACKGROUND: Platinum-based chemotherapy plays an antitumor role by damaging DNA. X-ray repair crosscomplementing protein 1 (XRCC1) participates in DNA repair and thus affects the sensitivity to platinum drugs. Two polymorphisms of XRCC1, rs25487 (Arg399Gln) and rs1799782 (Arg194Trp), have been widel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ningning, Ouyang, Yushu, Chang, Jianlan, Liu, Ping, Tian, Xiangyang, Yu, Junyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603545/
https://www.ncbi.nlm.nih.gov/pubmed/33150172
http://dx.doi.org/10.1155/2020/3520764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603545/
https://www.ncbi.nlm.nih.gov/pubmed/33150172
http://dx.doi.org/10.1155/2020/3520764

Ejemplares similares